Inside Precision Medicine December 12, 2025
How modular platforms, AI, and open ecosystems are reshaping genomic workflows, and why oncology and other fields will feel the impact first
Genomics has undergone a transformation so rapid that even seasoned scientists remark on its velocity. Sequencing costs that seemed impossibly low a decade ago have fallen further still. Spatial and single-cell technologies now populate not just top-tier institutes but mid-size research hospitals. Physicians increasingly expect molecular information at the time of diagnosis, not months later. The scientific imagination has expanded accordingly: whole-genome sequencing for newborn screening, single-cell atlases for entire organs, and tumor profiling in real-time during therapy are now normal.
Yet, amid this acceleration, a curious bottleneck has emerged. Sequencing, once the rate-limiting step, is often the...







